Recently added
This page was added on 04 June 2018.
Updates made
This page was updated on [date-counter-updated-date]. View history of updates
Sponsor
GlaxoSmithKline Australia
Administration route
Subcutaneous injection
Vaccine group
Monovalent vaccines
Description:
Registered for use in people aged ≥9 months.
Monovalent varicella vaccine
Lyophilised powder in a monodose vial with separate diluent.
Each 0.5 mL reconstituted dose contains:
- ≥103.3 plaque-forming units of live attenuated varicella-zoster virus (Oka strain)
- lactose
- mannitol
- sorbitol
- neomycin
For Product Information and Consumer Medicine Information about Varilrix visit the Therapeutic Goods Administration website.
Additional vaccine information
For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.
Page history
Last updated
Last reviewed
Related diseases